Edmond M. Kwan
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 25
- Cancer, Lipids, and Metabolism 9
-
- Prostate Cancer Treatment and Research 48
- Prostate Cancer Diagnosis and Treatment 11
- Renal cell carcinoma treatment 6
-
- PARP inhibition in cancer therapy 9
- Cancer Immunotherapy and Biomarkers 6
-
- Radiopharmaceutical Chemistry and Applications 19
- Co-authors
- Arun AzadHeidi FettkeAlexander W. WyattManish KohliLisa G. HorvathKate MahonShidong JiaTiantian Zheng
- Journals
- Journal of Clinical Oncology (12 papers)SHILAP Revista de lepidopterología (2 papers)Cancer Research (2 papers)
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Edmond M. Kwan
57 papers receiving 616 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 330
- Pulmonary and Respiratory Medicine 462
- Oncology 188
- Radiology, Nuclear Medicine and Imaging 115
- Pathology and Forensic Medicine 44
Countries citing papers authored by Edmond M. Kwan
This map shows the geographic impact of Edmond M. Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond M. Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond M. Kwan more than expected).
Fields of papers citing papers by Edmond M. Kwan
This network shows the impact of papers produced by Edmond M. Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond M. Kwan. The network helps show where Edmond M. Kwan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edmond M. Kwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 26 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 21 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 19 | |
| 9 | 2021 | 8 | |
| 10 | Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer | 2021 | 1 |
| 11 | 2021 | 11 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 31 | |
| 16 | 2020 | 89 | |
| 17 | 2020 | 1 | |
| 18 | 2019 | 11 | |
| 19 | 2019 | 4 | |
| 20 | Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs) | 2018 | 1 |
About Edmond M. Kwan
Edmond M. Kwan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 62 papers that have together received 622 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (48 papers), Cancer Genomics and Diagnostics (25 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Cancer, Lipids, and Metabolism (9 papers), PARP inhibition in cancer therapy (9 papers), Renal cell carcinoma treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (330 citations), Pulmonary and Respiratory Medicine (462 citations) and Oncology (188 citations). Edmond M. Kwan has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Arun Azad, Heidi Fettke, Alexander W. Wyatt, Manish Kohli, Lisa G. Horvath, Kate Mahon, Shidong Jia, Tiantian Zheng, Ben Tran and Pan Du. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.